Whole Genome Sequencing

At CMoC, whole genome sequencing (WGS) provides the most complete analysis of an individual’s genetic information, examining nearly all regions of DNA—both coding and non-coding. This depth allows clinicians to identify rare and common genetic variants that may influence disease risk, medication response, and long-term health planning.

We use MyOme for whole genome sequencing as part of our precision medicine program, ensuring high-quality, clinically meaningful genomic analysis.

How Whole Genome Sequencing Is Used

Whole genome sequencing supports a broad, integrated view of health. Rather than focusing on a single condition, this approach allows clinicians to combine hereditary risk, pharmacogenetic insights, and polygenic risk factors into a personalized care strategy.

Within precision medicine, WGS may inform:

• Personalized screening and surveillance recommendations

• Preventive strategies across multiple disease areas

• Medication selection and dosing considerations

• Long-term health planning as new evidence emerges

A Lifelong Foundation for Precision Medicine

Because the genome is sequenced once and can be reinterpreted as scientific knowledge evolves, whole genome sequencing offers lasting value. As new gene–disease and gene–drug relationships are discovered, existing data can be revisited to support ongoing, individualized care.

Sequencing Options & Pricing

Whole genome sequencing is offered in two tiers—a Base option and a Plus option—designed to reflect different levels of genomic depth and clinical insight. Your clinician will help determine which option is most appropriate based on your health history, goals, and desired level of analysis.